SCHEMBL208149

SCHEMBL208149

O=S(=O)(c1cc[c]c(Nc2ccc(F)cc2)c1)N1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
RXFP1 Q9HBX9 2/20 0.54
POLB P06746 2/20 0.52
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTT P42858 1/20 0.48
FKBP1A P62942 1/20 0.48
GLA P06280 1/20 0.48
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
NAMPT P43490 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208148 0.81 ALDH1A1 (0.60) MAPTRXFP1POLBKMT2AMEN1
SCHEMBL208150 0.80 POLB (0.73) MAPTRXFP1POLBKMT2AMEN1
SCHEMBL8723668 0.73 MAPK10 (0.38) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL4554939 0.73 USP2 (0.80) MAPTPOLBKMT2AMEN1SMN1; SMN2
SCHEMBL7096080 0.73 USP2 (0.80) MAPTPOLBKMT2AMEN1SMN1; SMN2
SCHEMBL427963 0.72 ALDH1A1 (0.49) MAPTPOLBKMT2AMEN1SMN1; SMN2
SCHEMBL3236916 0.71 MAPT (0.80) MAPTPOLBKMT2AMEN1SMN1; SMN2
SCHEMBL4164080 0.71 USP2 (0.50) MAPTPOLBKMT2AMEN1SMN1; SMN2
SCHEMBL27898439 0.69 USP2 (0.51) MAPTPOLBKMT2AMEN1SMN1; SMN2
SCHEMBL15076514 0.68 TP53 (0.78) MAPTKMT2AMEN1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 MAPT 2207/4885RXFP1 135/4885POLB 2513/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 MAPT 2207/4885RXFP1 135/4885POLB 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.